论文信息 - Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience. - 字舞流文

Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience.

D. Amarapurkar | N. Patel

[1] S. Schalm. Combination Therapy for Chronic Hepatitis B , 2005, Annals of Internal Medicine.

[2] B. McMahon,et al. [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. , 2004, Romanian journal of gastroenterology.

[3] Y. Chao,et al. Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B , 2003, Journal of viral hepatitis.

[4] F. Chan,et al. Combination of pegylated interferon and lamivudine is superior to lamivudine monotherapy in the treatment of chronic hepatitis B — a randomized trial , 2003 .

[5] H. Janssen,et al. Chronic HBV treatment with one year of pegylatyed-interferon alpha-2b (PEG-IFN) has a comparable safety profile to short term conventional interferon alpha-2b , 2003 .

[6] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.

[7] A. Lok,et al. Management of hepatitis B: 2000--summary of a workshop. , 2001, Gastroenterology.

[8] Ally,et al. A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B , 2000 .

[9] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .

[10] H. Janssen,et al. Repeated courses of α-interferon for treatment of chronic hepatitis type B , 1993 .

[11] R. D. de Man,et al. Repeated courses of alpha-interferon for treatment of chronic hepatitis type B. , 1993, Journal of hepatology.